11/12/2024 | Press release | Distributed by Public on 11/12/2024 09:39
Vanderbilt (VU + VUMC): This is a combined competition for VU and VUMC investigators. All investigators should follow these instructions.
VU and VUMC may each nominate one candidate for the Mary Kay Foundation Innovative/Translational Cancer Research Grant program for 2025. These awards provide $100,000 over two years to support innovative translational research for cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian, uterine, or cancers predominantly affecting women.
Overview
The Foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention, or treatment of cancer.
You can find a list of the previous award recipients here. Review additional guidelines in the RFP.
Eligibility:
Internal Application Process
Anyone interested in being considered as VU or VUMC's nominee must submit the following to [email protected] by 5 p.m. on Dec. 4. Please combine your materials into a single PDF and reference the program name in the subject line of the email.
The chosen nominee will submit a full proposal to the Foundation by the deadline of February 1, 2025. Direct all questions about this opportunity to [email protected]